We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dalton Pharma Services Licenses Thermo Fisher Scientific Enter Drug Development Agreement

News   May 07, 2008

 
Dalton Pharma Services Licenses Thermo Fisher Scientific Enter Drug Development Agreement
 
 
 

RELATED ARTICLES

Pancreatic Cancer: Mechanism of treatment-resistance discovered

News

Despite decades of research, treatments that can target a common mutation in the most frequently diagnosed type of pancreatic cancer have remained elusive. Now, researchers report they have discovered a mechanism of resistance to a treatment they’d identified as promising.

READ MORE

Arming Drug Hunters: Chemists design new reaction for drug discovery

News

The pair of Colorado State University organic chemists have forged a powerful new tool for drug hunters - a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.

READ MORE

New Inflammation Inhibitor Discovered

News

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE